<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="active. Graphical abstract Abstract The unprecedented pandemic of the severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) is threatening global health."/>
 <result pre="Graphical abstract Abstract The unprecedented pandemic of the severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) is threatening global health. The"/>
 <result pre="abstract Abstract The unprecedented pandemic of the severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) is threatening global health. The virus"/>
 <result pre="virus emerged in late 2019 and can cause a severe" exact="disease" post="associated with significant mortality. Several vaccine development and drug"/>
 <result pre="Keywords COVID-19 Coronavirus Protease inhibitors Peptidomimetics Antivirals Introduction The severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent"/>
 <result pre="COVID-19 Coronavirus Protease inhibitors Peptidomimetics Antivirals Introduction The severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of"/>
 <result pre="Coronavirus Protease inhibitors Peptidomimetics Antivirals Introduction The severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) is the causative agent of the"/>
 <result pre="(SARS-CoV-2) is the causative agent of the ongoing COVID-19 (coronavirus" exact="disease" post="2019) pandemic. Globally, 10 million infections have been confirmed"/>
 <result pre="the ongoing COVID-19 (coronavirus disease 2019) pandemic. Globally, 10 million" exact="infections" post="have been confirmed with 500,000 fatalities.1 The novel coronavirus"/>
 <result pre="in late 2019, where it caused a major cluster of" exact="atypical" post="pneumonia.2, 3, 4 Despite major efforts to contain the"/>
 <result pre="8 Following the 2002/2003 SARS and 2012 MERS (Middle East" exact="respiratory" post="syndrome) epidemics, this marks the third notable coronavirus outbreak"/>
 <result pre="pathogenic SARS-CoV, MERS-CoV and SARS-CoV-2,7, 11, 12 cause only mild" exact="respiratory" post="illness like the common cold.13 The case fatality rate"/>
 <result pre="case fatality rate (CFR) of COVID-19 is estimated to be" exact="lower" post="than for SARS (~10%) and MERS (~35%). However, its"/>
 <result pre="SARS-CoV-2 are still under controversial debate.14, 15 Undetected and asymptomatic" exact="infections" post="can challenge the accuracy of these parameters.16, 17, 18,"/>
 <result pre="their natural reservoir. Transmission to humans can occur via their" exact="intermediate" post="hosts palm civets (SARS) and dromedary camels (MERS).36 SARS-CoV-2"/>
 <result pre="bats as natural reservoir with a possibility for pangolins as" exact="intermediate" post="hosts.38, 44, 45, 46, 47, 48, 49 As the"/>
 <result pre="host-cell proteases are known with this substrate specificity.59, 60, 61" exact="Viral" post="proteases are well validated drug targets that have led"/>
 <result pre="that have led to various approved drugs, for example, against" exact="chronic" post="infections with human immunodeficiency virus (HIV) or hepatitis C"/>
 <result pre="have led to various approved drugs, for example, against chronic" exact="infections" post="with human immunodeficiency virus (HIV) or hepatitis C virus"/>
 <result pre="various approved drugs, for example, against chronic infections with human" exact="immunodeficiency" post="virus (HIV) or hepatitis C virus (HCV), which employ"/>
 <result pre="example, against chronic infections with human immunodeficiency virus (HIV) or" exact="hepatitis C" post="virus (HCV), which employ aspartyl and serine proteases, respectively.62"/>
 <result pre="functional proteins (Fig. 1), which is a critical step during" exact="viral" post="replication.29, 63, 64 Replication-essential enzymes such as RdRp or"/>
 <result pre="proteolytic release,56 positioning Mpro as a key enzyme in the" exact="viral" post="replication cycle. Consequently, its inhibition can stall the production"/>
 <result pre="replication cycle. Consequently, its inhibition can stall the production of" exact="infectious" post="viral particles and thus alleviate disease symptoms.23, 50, 65,"/>
 <result pre="cycle. Consequently, its inhibition can stall the production of infectious" exact="viral" post="particles and thus alleviate disease symptoms.23, 50, 65, 66,"/>
 <result pre="stall the production of infectious viral particles and thus alleviate" exact="disease" post="symptoms.23, 50, 65, 66, 67, 68 Capitalising on knowledge"/>
 <result pre="previous epidemical coronaviruses, Mpro is one of the most attractive" exact="viral" post="targets for antiviral drug discovery against SARS-CoV-2. Structure and"/>
 <result pre="the Mpro monomer is basically inactive, the homodimer is the" exact="primary" post="active species with both protomers almost orthogonally aligned to"/>
 <result pre="forms a hemithioacetal with Cys145. Î±-Ketoamides are already used as" exact="viral" post="serine protease warheads in the approved HCV drugs telaprevir"/>
 <result pre="the main protease of SARS-CoV-2 stands out as a promising" exact="viral" post="target, as it differs significantly from human proteases. Given"/>
 <result pre="drugs (e.g. telaprevir or afatinib).62, 105 Potential problems associated with" exact="limited" post="drug-likeness of peptidomimetics could be circumvented by pursuing alternative"/>
 <result pre="of global health concernLancet39510223202047047310.1016/S0140-6736(20)30185-931986257 3WuF.ZhaoS.YuB.A new coronavirus associated with human" exact="respiratory" post="disease in ChinaNature5797798202026526910.1038/s41586-020-2008-332015508 4ZhuN.ZhangD.WangW.A novel coronavirus from patients with"/>
 <result pre="global health concernLancet39510223202047047310.1016/S0140-6736(20)30185-931986257 3WuF.ZhaoS.YuB.A new coronavirus associated with human respiratory" exact="disease" post="in ChinaNature5797798202026526910.1038/s41586-020-2008-332015508 4ZhuN.ZhangD.WangW.A novel coronavirus from patients with pneumonia"/>
 <result pre="respiratory disease in ChinaNature5797798202026526910.1038/s41586-020-2008-332015508 4ZhuN.ZhangD.WangW.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N Engl J Med3828202072773310.1056/NEJMoa200101731978945 5ChanJ.-F.-W.YuanS.KokK.-H.A familial cluster"/>
 <result pre="patients with pneumonia in China, 2019N Engl J Med3828202072773310.1056/NEJMoa200101731978945 5ChanJ.-F.-W.YuanS.KokK.-H.A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="in China, 2019N Engl J Med3828202072773310.1056/NEJMoa200101731978945 5ChanJ.-F.-W.YuanS.KokK.-H.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="novel coronavirus epidemic in ChinaJ Autoimmun109202010243410.1016/j.jaut.2020.102434 7GuanW.NiZ.HuY.Clinical characteristics of coronavirus" exact="disease" post="2019 in ChinaN Engl J Med3821820201708172010.1056/NEJMoa200203232109013 8LauH.KhosrawipourV.KocbachP.The positive impact"/>
 <result pre="a 2-family cluster, Xuzhou, ChinaEmerg Infect Dis267202010.3201/eid2607.200718 17Wilder-SmithA.TelemanM.D.HengB.H.EarnestA.LingA.E.LeoY.S.Asymptomatic SARS coronavirus" exact="infection" post="among healthcare workers, SingaporeEmerg Infect Dis11720051142114510.3201/eid1107.04116516022801 18Al-TawfiqJ.A.GautretP.Asymptomatic Middle East"/>
 <result pre="infection among healthcare workers, SingaporeEmerg Infect Dis11720051142114510.3201/eid1107.04116516022801 18Al-TawfiqJ.A.GautretP.Asymptomatic Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) infection: extent and implications for infection"/>
 <result pre="among healthcare workers, SingaporeEmerg Infect Dis11720051142114510.3201/eid1107.04116516022801 18Al-TawfiqJ.A.GautretP.Asymptomatic Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) infection: extent and implications for infection control:"/>
 <result pre="East respiratory syndrome coronavirus (MERS-CoV) infection: extent and implications for" exact="infection" post="control: a systematic reviewTravel Med Infect Dis272019273210.1016/j.tmaid.2018.12.00330550839 19GandhiM.YokoeD.S.HavlirD.V.Asymptomatic transmission,"/>
 <result pre="drugsScience300562620031763176710.1126/science.108565812746549 24.WooP.C.Y.HuangY.LauS.K.P.YuenK.-Y.Coronavirus genomics and bioinformatics analysisViruses2820101804182010.3390/v208180321994708 25ZiebuhrJ.Molecular biology of severe" exact="acute" post="respiratory syndrome coronavirusCurr Opin Microbiol74200441241910.1016/j.mib.2004.06.00715358261 26GorbalenyaA.E.BakerS.C.BaricR.S.The species severe acute"/>
 <result pre="24.WooP.C.Y.HuangY.LauS.K.P.YuenK.-Y.Coronavirus genomics and bioinformatics analysisViruses2820101804182010.3390/v208180321994708 25ZiebuhrJ.Molecular biology of severe acute" exact="respiratory" post="syndrome coronavirusCurr Opin Microbiol74200441241910.1016/j.mib.2004.06.00715358261 26GorbalenyaA.E.BakerS.C.BaricR.S.The species severe acute respiratory"/>
 <result pre="genomics and bioinformatics analysisViruses2820101804182010.3390/v208180321994708 25ZiebuhrJ.Molecular biology of severe acute respiratory" exact="syndrome" post="coronavirusCurr Opin Microbiol74200441241910.1016/j.mib.2004.06.00715358261 26GorbalenyaA.E.BakerS.C.BaricR.S.The species severe acute respiratory syndrome-related"/>
 <result pre="severe acute respiratory syndrome coronavirusCurr Opin Microbiol74200441241910.1016/j.mib.2004.06.00715358261 26GorbalenyaA.E.BakerS.C.BaricR.S.The species severe" exact="acute" post="respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nat"/>
 <result pre="acute respiratory syndrome coronavirusCurr Opin Microbiol74200441241910.1016/j.mib.2004.06.00715358261 26GorbalenyaA.E.BakerS.C.BaricR.S.The species severe acute" exact="respiratory" post="syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nat Microbiol54202053654410.1038/s41564-020-0695-z32123347"/>
 <result pre="structure, function and inhibition by designed antiviral compoundsAntiviral Res1152015213810.1016/j.antiviral.2014.12.01525554382 34ZhouP.YangX.-L.WangX.-G.A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="epidemic: evidence for virus evolutionJ Med Virol924202045545910.1002/jmv.2568831994738 38LiX.ZaiJ.ZhaoQ.Evolutionary history, potential" exact="intermediate" post="animal host, and cross-species analyses of SARS-CoV-2J Med Virol92202060261110.1002/jmv.2573132104911"/>
 <result pre="origin and emergence of SARS-CoV-2Cell1812202022322710.1016/j.cell.2020.03.03532220310 49LauS.K.P.LukH.K.H.WongA.C.P.Possible bat origin of severe" exact="acute" post="respiratory syndrome coronavirus 2Emerg Infect Dis267202010.3201/eid2607.200092 50HilgenfeldR.PeirisM.From SARS to"/>
 <result pre="and emergence of SARS-CoV-2Cell1812202022322710.1016/j.cell.2020.03.03532220310 49LauS.K.P.LukH.K.H.WongA.C.P.Possible bat origin of severe acute" exact="respiratory" post="syndrome coronavirus 2Emerg Infect Dis267202010.3201/eid2607.200092 50HilgenfeldR.PeirisM.From SARS to MERS:"/>
 <result pre="emergence of SARS-CoV-2Cell1812202022322710.1016/j.cell.2020.03.03532220310 49LauS.K.P.LukH.K.H.WongA.C.P.Possible bat origin of severe acute respiratory" exact="syndrome" post="coronavirus 2Emerg Infect Dis267202010.3201/eid2607.200092 50HilgenfeldR.PeirisM.From SARS to MERS: 10"/>
 <result pre="important?Zool Res413202021321910.24272/j.issn.2095-8137.2020.03132314559 52ZhangC.HuangS.ZhengF.DaiY.Controversial treatments: an updated understanding of the coronavirus" exact="disease" post="2019J Med Virol202010.1002/jmv.25788 53LurieN.SavilleM.HatchettR.HaltonJ.Developing COVID-19 vaccines at pandemic speedN"/>
 <result pre="coronavirus genome expressionJ Gen Virol84920032305231510.1099/vir.0.19424-012917450 57YangH.YangM.DingY.The crystal structures of severe" exact="acute" post="respiratory syndrome virus main protease and its complex with"/>
 <result pre="genome expressionJ Gen Virol84920032305231510.1099/vir.0.19424-012917450 57YangH.YangM.DingY.The crystal structures of severe acute" exact="respiratory" post="syndrome virus main protease and its complex with an"/>
 <result pre="expressionJ Gen Virol84920032305231510.1099/vir.0.19424-012917450 57YangH.YangM.DingY.The crystal structures of severe acute respiratory" exact="syndrome" post="virus main protease and its complex with an inhibitorPNAS100232003131901319510.1073/pnas.183567510014585926"/>
 <result pre="enable antiviral drug designFEBS J2811820144085409610.1111/febs.1293625039866 62AgbowuroA.A.HustonW.M.GambleA.B.TyndallJ.D.A.Proteases and protease inhibitors in" exact="infectious" post="diseasesMed Res Rev38420181295133110.1002/med.2147529149530 63HegyiA.ZiebuhrJ.Conservation of substrate specificities among coronavirus"/>
 <result pre="SARS-coronavirus main proteaseCurr Top Med Chem64200636137610.2174/15680260677628709016611148 66SteuberH.HilgenfeldR.Recent advances in targeting" exact="viral" post="proteases for the discovery of novel antiviralsCurr Top Med"/>
 <result pre="of MERS coronavirus main proteasePLoS ONE10122015e014486510.1371/journal.pone.0144865 72PillaiyarT.ManickamM.NamasivayamV.HayashiY.JungS.-H.An overview of severe" exact="acute" post="respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small"/>
 <result pre="MERS coronavirus main proteasePLoS ONE10122015e014486510.1371/journal.pone.0144865 72PillaiyarT.ManickamM.NamasivayamV.HayashiY.JungS.-H.An overview of severe acute" exact="respiratory" post="syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule"/>
 <result pre="maturation of SARS-CoV main proteaseProtein Cell24201128229010.1007/s13238-011-1034-121533772 75MuramatsuT.KimY.-T.NishiiW.TeradaT.ShirouzuM.YokoyamaS.Autoprocessing mechanism of severe" exact="acute" post="respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its"/>
 <result pre="of SARS-CoV main proteaseProtein Cell24201128229010.1007/s13238-011-1034-121533772 75MuramatsuT.KimY.-T.NishiiW.TeradaT.ShirouzuM.YokoyamaS.Autoprocessing mechanism of severe acute" exact="respiratory" post="syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteinsFEBS"/>
 <result pre="SARS-CoV main proteaseProtein Cell24201128229010.1007/s13238-011-1034-121533772 75MuramatsuT.KimY.-T.NishiiW.TeradaT.ShirouzuM.YokoyamaS.Autoprocessing mechanism of severe acute respiratory" exact="syndrome" post="coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteinsFEBS J280920132002201310.1111/febs.1222223452147"/>
 <result pre="SARS-CoV 3CL proteaseJ Biol Chem280352005312573126610.1074/jbc.M50257720015788388 77ChouC.-Y.ChangH.-C.HsuW.-C.LinT.-Z.LinC.-H.ChangG.-G.Quaternary structure of the severe" exact="acute" post="respiratory syndrome (SARS) coronavirus main proteaseBiochemistry43472004149581497010.1021/bi049023715554703 78Ul QamarM.T.AlqahtaniS.M.AlamriM.A.ChenL.-L.Structural basis"/>
 <result pre="3CL proteaseJ Biol Chem280352005312573126610.1074/jbc.M50257720015788388 77ChouC.-Y.ChangH.-C.HsuW.-C.LinT.-Z.LinC.-H.ChangG.-G.Quaternary structure of the severe acute" exact="respiratory" post="syndrome (SARS) coronavirus main proteaseBiochemistry43472004149581497010.1021/bi049023715554703 78Ul QamarM.T.AlqahtaniS.M.AlamriM.A.ChenL.-L.Structural basis of"/>
 <result pre="proteaseJ Biol Chem280352005312573126610.1074/jbc.M50257720015788388 77ChouC.-Y.ChangH.-C.HsuW.-C.LinT.-Z.LinC.-H.ChangG.-G.Quaternary structure of the severe acute respiratory" exact="syndrome" post="(SARS) coronavirus main proteaseBiochemistry43472004149581497010.1021/bi049023715554703 78Ul QamarM.T.AlqahtaniS.M.AlamriM.A.ChenL.-L.Structural basis of SARS-CoV-2"/>
 <result pre="anti-COVID-19 drug designBioRxiv202010.1101/2020.03.07.981928 85FanK.WeiP.FengQ.Biosynthesis, purification, and substrate specificity of severe" exact="acute" post="respiratory syndrome coronavirus 3C-like proteinaseJ Biol Chem279320041637164210.1074/jbc.M31087520014561748 86CrooksG.E.HonG.ChandoniaJ.-M.BrennerS.E.WebLogo: a"/>
 <result pre="drug designBioRxiv202010.1101/2020.03.07.981928 85FanK.WeiP.FengQ.Biosynthesis, purification, and substrate specificity of severe acute" exact="respiratory" post="syndrome coronavirus 3C-like proteinaseJ Biol Chem279320041637164210.1074/jbc.M31087520014561748 86CrooksG.E.HonG.ChandoniaJ.-M.BrennerS.E.WebLogo: a sequence"/>
 <result pre="designBioRxiv202010.1101/2020.03.07.981928 85FanK.WeiP.FengQ.Biosynthesis, purification, and substrate specificity of severe acute respiratory" exact="syndrome" post="coronavirus 3C-like proteinaseJ Biol Chem279320041637164210.1074/jbc.M31087520014561748 86CrooksG.E.HonG.ChandoniaJ.-M.BrennerS.E.WebLogo: a sequence logo"/>
 <result pre="the past: possible urgent prevention and treatment options for severe" exact="acute" post="respiratory infections caused by 2019-nCoVChemBioChem215202073073810.1002/cbic.20200004732022370 88BzÃ³wkaM.MitusiÅ&quot;skaK.RaczyÅ&quot;skaA.SamolA.TuszyÅ&quot;skiJ.A.GÃ³raA.Structural and evolutionary analysis"/>
 <result pre="past: possible urgent prevention and treatment options for severe acute" exact="respiratory" post="infections caused by 2019-nCoVChemBioChem215202073073810.1002/cbic.20200004732022370 88BzÃ³wkaM.MitusiÅ&quot;skaK.RaczyÅ&quot;skaA.SamolA.TuszyÅ&quot;skiJ.A.GÃ³raA.Structural and evolutionary analysis indicate"/>
 <result pre="possible urgent prevention and treatment options for severe acute respiratory" exact="infections" post="caused by 2019-nCoVChemBioChem215202073073810.1002/cbic.20200004732022370 88BzÃ³wkaM.MitusiÅ&quot;skaK.RaczyÅ&quot;skaA.SamolA.TuszyÅ&quot;skiJ.A.GÃ³raA.Structural and evolutionary analysis indicate that"/>
 <result pre="(ML188) as potent noncovalent small molecule inhibitors of the severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) 3CL proteaseJ Med Chem562201353454610.1021/jm301580n23231439 98St."/>
 <result pre="as potent noncovalent small molecule inhibitors of the severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) 3CL proteaseJ Med Chem562201353454610.1021/jm301580n23231439 98St. John"/>
 <result pre="potent noncovalent small molecule inhibitors of the severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) 3CL proteaseJ Med Chem562201353454610.1021/jm301580n23231439 98St. John SE,"/>
 <result pre="proteaseBioRxiv202010.1101/2020.05.27.118117 102MaC.SaccoM.D.HurstB.Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2" exact="viral" post="replication by targeting the viral main proteaseCell Res202010.1038/s41422-020-0356-z 103SteinmetzerT.PilgramO.WenzelB.M.WiedemeyerS.J.A.Fibrinolysis"/>
 <result pre="inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the" exact="viral" post="main proteaseCell Res202010.1038/s41422-020-0356-z 103SteinmetzerT.PilgramO.WenzelB.M.WiedemeyerS.J.A.Fibrinolysis inhibitors: potential drugs for the"/>
 <result pre="dose-ranging study of efegatran sulfate versus heparin with thrombolysis for" exact="acute" post="myocardial infarction: the promotion of reperfusion in myocardial infarction"/>
 <result pre="thrombolysis for acute myocardial infarction: the promotion of reperfusion in" exact="myocardial infarction" post="evolution (PRIME) trialAm Heart J143120029510510.1067/mhj.2002.11989611773918 105JacksonP.A.WidenJ.C.HarkiD.A.BrummondK.M.Covalent modifiers: a chemical"/>
 <result pre="the promotion of reperfusion in myocardial infarction evolution (PRIME) trialAm" exact="Heart" post="J143120029510510.1067/mhj.2002.11989611773918 105JacksonP.A.WidenJ.C.HarkiD.A.BrummondK.M.Covalent modifiers: a chemical perspective on the reactivity"/>
</results>
